Conmed (CNMD) Market Capitalization (2010 - 2026)

Conmed (CNMD) has reported Market Capitalization for 17 consecutive years, with $980.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization fell 39.19% year-over-year to $980.3 million; the trailing twelve-month figure through Jun 2026 stood at $980.3 million (down 39.19% YoY), and the FY2025 full-year result was $1.3 billion, down 40.82% from the prior year.
• Market Capitalization declined to $980.3 million in Q2 2026 per CNMD's latest filing, from $1.1 billion in the prior quarter.
• Across five years, Market Capitalization topped out at $4.4 billion in Q1 2022 and bottomed at $980.3 million in Q2 2026.
• Historically, Market Capitalization has averaged $2.4 billion across 5 years, with a median of $2.3 billion in 2022.
• The sharpest annual moves came in 2023 and 2024: Market Capitalization soared 43.18% in 2023, then tumbled 48.84% in 2024.
• Over 5 years, Market Capitalization stood at $2.7 billion in 2022, then rose by 24.68% to $3.4 billion in 2023, then sank by 37.24% to $2.1 billion in 2024, then plunged by 40.82% to $1.3 billion in 2025, then retreated by 21.69% to $980.3 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $980.3 million, $1.1 billion, and $1.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.